Report
Valens Research

IOSP - Embedded Expectations Analysis - 2019 10 23

Innospec Inc. (IOSP:USA) currently trades below corporate averages relative to UAFRS-based (Uniform) Earnings, with a 17.6x Uniform P/E. At these levels, the market has bearish expectations for the firm, and management may be concerned about their pipeline, inventory, and margins.

Specifically, management may lack confidence in their ability to continue driving margin improvement, and they may lack confidence in their ability to quickly return to normal operations following the recent cyber-attack. Furthermore, they may be concerned about the strength of their pipeline, and they may be concerned about potential oil price-related headwinds. Finally, they may be concerned about the impact of their recent raw material disruption on inventories in Q3.
Underlying
Innospec Inc.

Innospec develops, manufactures, blends, markets and supplies chemicals for use as fuel additives, and ingredients for personal care, home care, agrochemical, mining and other applications and oilfield chemicals. The company has four segments: Fuel Specialties, which develops, manufactures, blends, markets and supplies a range of chemical products; Performance Chemicals, which provides products focused on the personal care, home care, agrochemical and mining markets; Oilfield Services, which develops and markets products to prevent loss of mud in drilling operations, and chemical solutions; and Octane Additives, which comprises sales of tetra ethyl lead for use in automotive gasoline.

Provider
Valens Research
Valens Research

In 2009, just as the dust was settling from the last major equity and credit market crises, we launched a boutique research firm with the intention of breaking Wall Street’s biases and broken incentives:

  • GAAP and IFRS have failed to provide rules for reliable financial statement reporting
  • Stock analyst recommendations are not grounded in disciplined financial analysis
  • Credit agencies have been set up to grossly fail in their responsibilities to investors and the public markets
  • Utter lack of willingness of major research firms to employ the the most advanced forensic analysis available

We sought to provide investors and company analysts with a source of information that changed all that.
Many years later, our business model remains because little has changed on Wall Street.

  • Corporate credit ratings remain years behind the fundamental underpinnings of company performance
  • Stock analysts continue to make recommendations with deeply inherent biases
  • Research firms have failed to break down the walls between credit, equity, and macroeconomic research
  • The governing accounting bodies have created more leeway for mis-estimates and mis-classifications as financials have become unwieldy and overwhelming

The integrity of Valens Research is founded in our disciplined processes and analytics. No “star” analysts. No corporate advisory relationships. No-nonsense opinions and recommendations.

Analysts
Valens Research

Other Reports on these Companies
Other Reports from Valens Research

ResearchPool Subscriptions

Get the most out of your insights

Get in touch